Myopathy is a life-threatening disease that can be caused, among other things, by the intake
of various medications. Despite the fact that many drug-induced myopathies are well known …

Colchicine and statins are frequently co‐prescribed for prevention and treatment of
cardiovascular diseases, auto‐inflammatory diseases, and gout. Both are substrates and …

Background HMG-CoA reductase inhibitors [statins], a widely prescribed cholesterol-
lowering therapy, are associated with muscle-related adverse events. While characteristics …

OBJECTIVE To report a case of acute myopathy after concomitant use of colchicine and
pravastatin. CASE SUMMARY A 65-year-old woman was admitted to the hospital with an …

Statins and colchicine co-administration consists of a potentially catastrophic drug–drug
interaction since it provokes myotoxicity, myopathy and various degrees of rhabdomyolysis …

We report a case of a patient with mild chronic renal insufficiency who had been taking
simvastatin for over a year and developed acute weakness within 3 weeks after the start of …

Reports of myopathy and rhabdomyolysis with statins are a reminder to prescribers to
measure creatine kinase (CK) levels in patients presenting with muscle pain or weakness …

To report a case of colchicine-induced rhabdomyolysis and neuromyopathy in a patient
treated with atorvastatin and colchicine and to review the literature about this topic. A 69 …

Abstract Colchicine and 3-hydroxy-3-methy-glutaryl coenzyme A (HMG-CoA) reductase
inhibitors are well known to cause myopathy. Myotoxicity is dose-dependent in both drugs; …

Iatrogenic disease, mostly accounted for by complications of the use of therapeutic drugs,
presents an enormous burden in Western medicine. The incidence is higher in the elderly …